- Home
- WSBC vs APLS Comparison
WSBC vs APLS Comparison
Compare WSBC & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- APLS
- Stock Information
- Founded
- WSBC 1870
- APLS 2009
- Country
- WSBC United States
- APLS United States
- Employees
- WSBC N/A
- APLS N/A
- Industry
- WSBC Major Banks
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- WSBC Finance
- APLS Health Care
- Exchange
- WSBC Nasdaq
- APLS Nasdaq
- Market Cap
- WSBC 3.1B
- APLS 3.3B
- IPO Year
- WSBC N/A
- APLS 2017
- Fundamental
- Price
- WSBC $30.56
- APLS $25.52
- Analyst Decision
- WSBC Buy
- APLS Buy
- Analyst Count
- WSBC 5
- APLS 18
- Target Price
- WSBC $41.40
- APLS $45.53
- AVG Volume (30 Days)
- WSBC 792.2K
- APLS 1.5M
- Earning Date
- WSBC 04-22-2025
- APLS 02-28-2025
- Dividend Yield
- WSBC 4.80%
- APLS N/A
- EPS Growth
- WSBC N/A
- APLS N/A
- EPS
- WSBC 2.26
- APLS N/A
- Revenue
- WSBC $586,985,000.00
- APLS $781,367,000.00
- Revenue This Year
- WSBC $42.18
- APLS $12.95
- Revenue Next Year
- WSBC $11.64
- APLS $21.35
- P/E Ratio
- WSBC $13.75
- APLS N/A
- Revenue Growth
- WSBC 0.50
- APLS 97.02
- 52 Week Low
- WSBC $25.56
- APLS $23.77
- 52 Week High
- WSBC $37.36
- APLS $60.64
- Technical
- Relative Strength Index (RSI)
- WSBC 25.54
- APLS 39.75
- Support Level
- WSBC $31.92
- APLS $24.43
- Resistance Level
- WSBC $37.18
- APLS $26.15
- Average True Range (ATR)
- WSBC 1.03
- APLS 1.29
- MACD
- WSBC -0.59
- APLS -0.00
- Stochastic Oscillator
- WSBC 0.81
- APLS 33.59
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company that offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. The company has two reportable segments: community banking and trust and investment services. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. Its market service area primarily includes the Rust Belt region of the United States. Commercial real estate accounts for nearly half of the bank's loan portfolio. The bank has historically grown through both organic growth and acquisitions. The bank's primary component of net revenue is net interest income.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.